| Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL) (NCT02535364) | Juno Therapeutics, a Subsidiary of Celgene | 2015-08-21 |
| Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD) (NCT02615938) | Matthias Griese | 2015-08-21 |
| Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL (NCT02393157) | New York Medical College | 2015-08-21 |
| Study of Orofacial Pain and PropRANOlol (NCT02437383) | University of North Carolina, Chapel Hill | 2015-08-20 |
| A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis (NCT02473393) | Otsuka Pharmaceutical Co., Ltd. | 2015-08-20 |
| A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA). (NCT02462759) | Biogen | 2015-08-19 |
| Fecal Microbiota Transplantation As a Potential Treatment for Parkinson's Disease (NCT03876327) | Soroka University Medical Center | 2015-08-19 |
| Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous (NCT02320357) | University Hospital, Bordeaux | 2015-08-19 |
| Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study (NCT02748707) | Tata Memorial Hospital | 2015-08-18 |
| Trial of pIL-12/MK-3475 in Metastatic Melanoma (NCT02493361) | University of California, San Francisco | 2015-08-17 |
| Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer (NCT02404506) | Swiss Cancer Institute | 2015-08-17 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis (NCT02525094) | MedImmune LLC | 2015-08-15 |
| Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis (NCT02174432) | Trevi Therapeutics | 2015-08-15 |
| Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease (NCT02471196) | Orion Corporation, Orion Pharma | 2015-08-14 |
| Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors (NCT02372409) | Washington University School of Medicine | 2015-08-14 |
| Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) (NCT02447887) | Fox Chase Cancer Center | 2015-08-14 |
| GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma (NCT02499003) | Johannes Gutenberg University Mainz | 2015-08-14 |
| Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer (NCT02522715) | OHSU Knight Cancer Institute | 2015-08-13 |
| Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension (NCT02531217) | aTyr Pharma, Inc. | 2015-08-13 |
| Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer (NCT02491632) | M.D. Anderson Cancer Center | 2015-08-13 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery (NCT02500797) | National Cancer Institute (NCI) | 2015-08-13 |
| Safety Of Fat Micrografts With Adipose-Derived Stromal Vascular Fraction In Hands Of Patients With Systemic Sclerosis (NCT04387825) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2015-08-13 |
| P1101 in Treating Patients With Myelofibrosis (NCT02370329) | Mayo Clinic | 2015-08-12 |
| A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia. (NCT02450877) | Celgene | 2015-08-12 |
| Sirolimus for the Treatment of Hyperinsulinism (NCT02524639) | Children's Hospital of Philadelphia | 2015-08-12 |
| Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B) (NCT04439136) | National Cancer Institute (NCI) | 2015-08-12 |
| Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q) (NCT04439110) | National Cancer Institute (NCI) | 2015-08-12 |
| Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors (NCT02451007) | PharmaMar | 2015-08-12 |
| A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population (NCT02626754) | vghtpe user | 2015-08-12 |
| Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G) (NCT04439253) | National Cancer Institute (NCI) | 2015-08-12 |
| Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F) (NCT04439266) | National Cancer Institute (NCI) | 2015-08-12 |
| Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R) (NCT04439279) | National Cancer Institute (NCI) | 2015-08-12 |
| A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) (NCT02484690) | Hoffmann-La Roche | 2015-08-11 |
| Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT02489123) | University of Washington | 2015-08-11 |
| Effects of Sevoflurane and Desflurane on Treg (NCT02559297) | Mahidol University | 2015-08-10 |
| Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age (NCT02576639) | Novartis Pharmaceuticals | 2015-08-10 |
| Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer (NCT02676986) | Queen Mary University of London | 2015-08-10 |
| Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC) (NCT02435680) | Novartis Pharmaceuticals | 2015-08-10 |
| LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer (NCT02538471) | Weill Medical College of Cornell University | 2015-08-10 |
| An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert (NCT02537015) | ForSight Vision5, Inc. | 2015-08-10 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02498600) | National Cancer Institute (NCI) | 2015-08-10 |
| Safe@Home: A Self-Management Program for Individuals With TBI and Their Families (NCT02893345) | Shepherd Center, Atlanta GA | 2015-08-08 |
| Mesenchymal Stemcells for Radiation Induced Xerostomia (NCT02513238) | Rigshospitalet, Denmark | 2015-08-08 |
| Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317) (NCT02413138) | Versartis Inc. | 2015-08-08 |
| Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma (NCT02505269) | Massachusetts General Hospital | 2015-08-07 |
| Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma (NCT02500576) | M.D. Anderson Cancer Center | 2015-08-07 |
| Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders (NCT02930005) | The University of Texas Health Science Center, Houston | 2015-08-07 |
| Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS) (NCT02354261) | HedgePath Pharmaceuticals, Inc. | 2015-08-07 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease (NCT02519036) | Ionis Pharmaceuticals, Inc. | 2015-08-06 |
| Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck (NCT02499328) | AstraZeneca | 2015-08-06 |
| A Healthy Volunteer PK/PD, Safety and Tolerability Study of Andexanet After Betrixaban Dosing (NCT03330457) | Portola Pharmaceuticals | 2015-08-06 |
| A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer (NCT02450539) | Eli Lilly and Company | 2015-08-06 |
| A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris (NCT02656485) | AOBiome LLC | 2015-08-05 |
| MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas (NCT02311582) | Washington University School of Medicine | 2015-08-05 |
| Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis (NCT02424734) | Pfizer | 2015-08-04 |
| An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy (NCT02472145) | Janssen Research & Development, LLC | 2015-08-04 |
| Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia (NCT02427451) | Kerry Rogers | 2015-08-03 |
| Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) (NCT02547428) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2015-08-03 |
| Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer (NCT02312622) | Joel Neal | 2015-08-01 |
| A4250, an IBAT Inhibitor in Pediatric Cholestasis (NCT02630875) | Albireo | 2015-08-01 |
| The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil (NCT02530697) | University of Brasilia | 2015-08-01 |
| Platelet Reactivity in Acute Non-disabling Cerebrovascular Events (NCT02506140) | Beijing Tiantan Hospital | 2015-08-01 |
| Aftercare Focus Study (AFS): A Clinical Trial to Reduce Short-Term Suicide Risk After Hospitalization (NCT04693845) | University of Washington | 2015-08-01 |
| Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer (NCT02525237) | Qingdao Municipal Hospital | 2015-08-01 |
| Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation (NCT02538367) | Yuhan Corporation | 2015-08-01 |
| NEUROIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the Knee Joint (NCT02967302) | Hildrun Haibel | 2015-08-01 |
| Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands (NCT02602275) | Biologische Heilmittel Heel GmbH | 2015-08-01 |
| Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer (NCT02577341) | Sun Yat-sen University | 2015-08-01 |
| Anfibatide Treatment in STEMI Patients (NCT02495012) | Lee's Pharmaceutical Limited | 2015-08-01 |
| A First in Human Study of RT001 in Patients With Friedreich's Ataxia (NCT02445794) | Biojiva LLC | 2015-08-01 |
| Ginger Capsules for the Chronic Treatment of Obesity (NCT02742194) | Federal University of Minas Gerais | 2015-08-01 |
| Xia Shi Surgical Treatment for Eczema Multi-center Clinical Research (NCT02517957) | Shanghai Yueyang Integrated Medicine Hospital | 2015-08-01 |
| Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer (NCT02529878) | The First Affiliated Hospital of Zhejiang Chinese Medical University | 2015-08-01 |
| A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis (NCT02578914) | Aldeyra Therapeutics, Inc. | 2015-08-01 |
| DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer (NCT02415699) | Sixth Affiliated Hospital, Sun Yat-sen University | 2015-08-01 |
| Lenalidomide for Adult Histiocyte Disorders (NCT02523040) | Dana-Farber Cancer Institute | 2015-08-01 |
| Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin (NCT02562599) | Hubei Cancer Hospital | 2015-08-01 |
| Drug Trial to Investigate the Safety and Efficacy of Niclosamide Tablets in Patients With Metastases of a Colorectal Cancer Progressing After Therapy (NCT02519582) | Charite University, Berlin, Germany | 2015-08-01 |
| Effects of Berry Peel Intake on Glucose Metabolism in Healthy Subjects (NCT02533986) | Lund University | 2015-08-01 |
| Efficacy of Tranexamic Acid In Reducing Blood Loss During Cesarean Section Because Of Placenta Previa (NCT02688127) | Medical Research Council | 2015-08-01 |
| CIK in Treating Patients With Esophageal Cancer (NCT02490735) | The First People's Hospital of Changzhou | 2015-08-01 |
| Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss? (NCT02520518) | Christopher Bell | 2015-08-01 |
| DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating (NCT02487550) | The First People's Hospital of Changzhou | 2015-08-01 |
| Infra-orbital Nerve Block for Post Operative Analgesia in Children Undergoing Cleft Lip Surgery. (NCT02514980) | Assiut University | 2015-08-01 |
| Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir (NCT02513901) | Tang-Du Hospital | 2015-08-01 |
| Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant (NCT02490202) | Prolong Pharmaceuticals | 2015-08-01 |
| Aprepitant Versus Gabapentin Prophylaxis for Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgeries (NCT02525848) | Assiut University | 2015-08-01 |
| Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis (NCT02465437) | Corbus Pharmaceuticals Inc. | 2015-08-01 |
| The Research of Standard Diagnosis and Treatment for HSPN in Children (NCT02532777) | Nanjing Children's Hospital | 2015-08-01 |
| Extension Study of MT-1303 in Subjects With Crohn's Disease (NCT02389790) | Tanabe Pharma Corporation | 2015-08-01 |
| Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder (NCT02354703) | University of Maryland, Baltimore | 2015-08-01 |
| Stem Cell Therapy for Outer Retinal Degenerations (NCT02903576) | Federal University of São Paulo | 2015-08-01 |
| Pharmacokinetics of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance Regimen (NCT02566707) | Radboud University Medical Center | 2015-08-01 |
| Safety, Tolerability and Efficacy of Single Dose Low Cost Minipool Intravenous Immunoglobulins in Moderately Severe Newly Diagnosed ITP (NCT02669277) | Ain Shams University | 2015-08-01 |
| Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication (NCT02486289) | EmeraMed | 2015-08-01 |
| Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy (NCT02522598) | Vivozon, Inc. | 2015-08-01 |
| The Research of Standard Diagnosis and Treatment for Severe HSP in Children (NCT02540720) | Nanjing Children's Hospital | 2015-08-01 |
| A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers (NCT02238808) | AHS Cancer Control Alberta | 2015-08-01 |
| RejuvenAir Lobectomy for Safety and Histology (NCT02483052) | CSA Medical, Inc. | 2015-08-01 |